Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Simris Alg ABFRA:5LU -15.15%19 Gross Margin % is 53.85% as of Mar. 2026. GuruFocus rates FRA:5LU with a GF Score™ of 19/100. The stock has 6 warning signs investors should review. Among 733 Biotechnology companies, Simris Alg AB ranks better than 98.77% on this metric.
The historical rank and industry rank for Simris Alg AB's Gross Margin % or its related term are showing as below:
FRA:5LU'
s Gross Margin % Range Over the Past 10 Years
Min: -126.92 Med: -25.94 Max: 289.91
Current: 101.54
During the past 12 years, the highestGross Margin % of Simris Alg AB was 289.91%. The lowest was -126.92%. And the median was -25.94%.
FRA:5LU's Gross Margin % is ranked better than 98.77% of 733
companies
in the Biotechnology industry
Industry Median: 60.91
vs FRA:5LU: 101.54
Simris Alg AB had a gross margin of 53.85% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Simris Alg AB was 0.00% per year.
Simris Alg AB (FRA:5LU) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Simris Alg AB had a gross margin of 53.85% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Simris Alg AB Gross Margin % Related Terms
Simris Alg AB Gross Margin % Historical Data
* Premium members only.
The historical data trend for Simris Alg AB's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:5LU vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Simris Alg AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Simris Alg AB Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Simris Alg AB's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Simris Alg AB's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Simris Alg AB (FRA:5LU) has a Gross Margin % of 53.85% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Simris Alg AB and its competitors. According to the industry distribution chart, Simris Alg AB ranks #9 out of 733 companies in the Biotechnology industry, placing it in the top 1.2%.
Is Simris Alg AB's Gross Margin % too high?
Simris Alg AB's current Gross Margin % is 53.85%. The Biotechnology industry median Gross Margin % is 60.91. Simris Alg AB's value of 53.85% is 11.6% below this industry median. Based on the distribution chart, Simris Alg AB ranks #9 out of 733 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Simris Alg AB has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Simris Alg AB's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Simris Alg AB ranks #9 out of 733 companies for Gross Margin %. This places Simris Alg AB in the top 1% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 60.91. Simris Alg AB's value of 53.85% is 11.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.91, based on 733 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Simris Alg AB's current Gross Margin % of 53.85% is 11.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Simris Alg AB and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Simris Alg AB's current Gross Margin % is 53.85%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Simris Alg AB stock overvalued right now?
Simris Alg AB (FRA:5LU) has a current Gross Margin % of 53.85%. The current Gross Margin % is 53.85% and 11.6% below the Biotechnology industry median of 60.91. Simris Alg AB's overall GF Score™ is 19/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Simris Alg AB (FRA:5LU), the current Gross Margin % is 53.85% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Simris Alg AB is a biotechnology company, engaged in research, development and production of bioactive substances from microalgae, for nutraceutical, cosmeceutical and pharmaceutical applications. The company's technology provides access to bioactive substances with novel functions, while replacing unsustainable raw materials from endangered marine species and ecosystems. Its first commercialised range is a series of omega-3 health supplements marketed under the company's own brand.
19GF Score
Get the complete analysis for FRA:5LU
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5LU has been successfully added to your 
